The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032
The Business Research Company’s bladder cancer drugs market report forecasts the bladder cancer drugs market size to grow to $4.31 Billion by 2027, with a CAGR (compound annual growth rate) of almost 13%.
Learn More On The Bladder Cancer Drugs Market Report 2023 – https://www.thebusinessresearchcompany.com/report/bladder-cancer-drugs-global-market-report
Bladder Cancer Drugs Market Size Forecast
The global bladder cancer drugs market is expected to grow from $2.32 billion in 2022 to $2.66 billion in 2023 at a compound annual growth rate (CAGR) of 14.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global bladder cancer drugs market size is expected to grow to $4.31 billion in 2027 at a CAGR of 12.9%.
North America held the largest bladder cancer drugs market share, and Middle East was the fastest-growing region in 2022.
Key Bladder Cancer Drugs Market Driver – Increase In Smoking Habits, And Consuming Water
According to the American Cancer Society, there were 81,400 new cases of bladder cancer in 2020 out of which a total of 62,100 cases were in men and 19,300 cases in women. This increased incidence of bladder cancer increases the demand for bladder cancer drugs, contributing to the growth of the market.
Request for A Sample Of The Global Bladder Cancer Drugs Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2586&type=smp
Key Bladder Cancer Drugs Market Trend – Adopting Gene Therapy
Gene therapy is a medical approach that treats or prevents disease by correcting the underlying genetic problem by altering a person’s genetic makeup. For example, in December 2022, the US Food and Drug Administration (FDA), a federal agency of the Department of Health and Human Services in USA, approved Adstiladrin (nadofaragene firadenovec-vncg), a non-replicating (cannot multiply in human cells) adenoviral vector based gene therapy indicated for the treatment of adult patients with high-risk Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle-invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) with or without papillary tumors.
Bladder Cancer Drugs Market Segment
1) By Type: Non-Muscle-Invasive Bladder Cancer, Muscle-Invasive Bladder Cancer
2) By Application: Low-Grade Tumors, High-Grade Tumors
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels
Bladder Cancer Drugs Market Major Players and Strategies
Major players in the bladder cancer drugs market are Pfizer, Celgene Corporation, Eli Lilly, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Sanofi, Hoffmann-La Roche, Novartis International, and Johnson & Johnson.
In August 2022, Merck & Co., a US-based pharmaceutical company, acquired Seagen for a deal amount of $40 billion. Through this acquisition, Merck & Co. expands its business in oncology. SeagenInc. is a US-based bio-technology company that develops various cancer drugs including bladder cancer drugs.
The Bladder Cancer Drugs Global Market Report 2023 covers regional data on bladder cancer drugs market size, bladder cancer drugs market trends and drivers, opportunities, strategies, and bladder cancer drugs market competitor analysis. The countries covered in the bladder cancer drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.
The bladder cancer drugs market consists of sales of bladder cancer drugs. Bladder cancer is cancerous tissue that occurs on the lining of the bladder. These cancerous tissues are also called tumors, and they have the potential to spread to other nearby cells and tissues if not treated soon. The bladder cancer market consists of treatments for bladder cancer types such as urothelial carcinoma, squamous cell bladder cancer, adenocarcinoma, and others.
View More Reports Related To The Bladder Cancer Drugs Market –
Blood Cancer Drugs Global Market Report 2023
Cancer Tumor Profiling Global Market Report 2023
Cancer Diagnostics Global Market Report 2023
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
